A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

Clinical trial NCT07285304 · RECRUITING

Trial details

NCT number: NCT07285304
Sponsor: Taisho Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hyperphosphatemia Patients on Hemodialysis

Start date: 2025-12-01
Primary completion: 2027-07-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.